1. Xu, Chengfei, Wang, Yahui, Ni, Chaobo, Yao, Ming, Ni, Huadong. 2024. Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models. In EMBO reports, 25, 5429-5455. doi:10.1038/s44319-024-00292-6. https://pubmed.ncbi.nlm.nih.gov/39448865/
2. Yang, Hua, Liu, Haipeng, Chen, Hao, Liu, Feng, Ge, Baoxue. 2016. G protein-coupled receptor160 regulates mycobacteria entry into macrophages by activating ERK. In Cellular signalling, 28, 1145-1151. doi:10.1016/j.cellsig.2016.05.022. https://pubmed.ncbi.nlm.nih.gov/27259691/
3. Zhou, Caihong, Dai, Xinchuan, Chen, Yi, Ding, Jian, Wang, Ming-Wei. . G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells. In Oncotarget, 7, 12823-39. doi:10.18632/oncotarget.7313. https://pubmed.ncbi.nlm.nih.gov/26871479/
4. Abbas, Azar, Jun, Peng, Yuan, Jiang Yuan, Jiang, Jinwei, Yuan, Shengtao. 2022. Downregulation of GPR160 inhibits the progression of glioma through suppressing epithelial to mesenchymal transition (EMT) biomarkers. In Basic & clinical pharmacology & toxicology, 131, 241-250. doi:10.1111/bcpt.13769. https://pubmed.ncbi.nlm.nih.gov/35771163/
智鼠故事 
